Inhibition of Initiation of Simian Virus 40 DNA Replication in Infected BSC-1 Cells by the DNA Alkylating Drug Adozelesin
Open Access
- 1 August 1996
- journal article
- Published by Elsevier
- Vol. 271 (33), 19852-19859
- https://doi.org/10.1074/jbc.271.33.19852
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Phase I Study of Adozelesin Administered by 24-Hour Continuous Intravenous InfusionJNCI Journal of the National Cancer Institute, 1994
- Evaluation of the antineoplastic activity of Adozelesin alone and in combination with 5-aza-2-deoxycytidine and cytosine arabinoside on DLD-1 human colon carcinoma cellsAnti-Cancer Drugs, 1993
- Comparison of U-73,975 and cisplatin cytotoxicity in fresh cervical and ovarian carcinoma specimens with the ATP-chemosensitivity assayGynecologic Oncology, 1992
- Adozelesin, a potent new alkylating agent: cell-killing kinetics and cell-cycle effectsCancer Chemotherapy and Pharmacology, 1992
- Resistance of CHO cells expressing P-glycoprotein to cyclopropylpyrroloindole (CPI) alkylating agentsBiochemical Pharmacology, 1992
- Effect of the (+)-CC-1065-(N3-adenine)DNA adduct on in vitro DNA synthesis mediated by Escherichia coli DNA polymeraseBiochemistry, 1992
- In vitro evaluation of a novel chemotherapeutic agent, adozelesin, in gynecologic-cancer cell linesCancer Chemotherapy and Pharmacology, 1992
- In vitro and in vivo DNA bonding by the CC-1065 analog U-73975Biochemistry, 1991
- Adozelesin, a selected lead among cyclopropylpyrroloindole analogs of the DNA-binding antibiotic, CC-1065Investigational New Drugs, 1991
- Stereoelectronic factors influencing the biological activity and DNA interaction of synthetic antitumor agents modeled on CC-1065Journal of Medicinal Chemistry, 1988